Agreed G if they could do a deal with Nurofen then that in itself would be a Co maker given the size of Nurofen.
Another snippet from the Q:
The current PainChek® RAC sales penetration equates to 1.5% of the potential Australian Aged Care market. We have a significantly large and growing number of new potential clients include a range of large, medium and small RAC operators either in trial or in contract negotiation.
Agreed G if they could do a deal with Nurofen then that in...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
